BlackRock Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $442K | Buy |
61,529
+10,873
| +21% | +$78.1K | ﹤0.01% | 2217 |
|
2016
Q3 | $474K | Buy |
50,656
+34,741
| +218% | +$325K | ﹤0.01% | 2152 |
|
2016
Q2 | $101K | Buy |
15,915
+547
| +4% | +$3.47K | ﹤0.01% | 2909 |
|
2016
Q1 | $85K | Buy |
15,368
+2,959
| +24% | +$16.4K | ﹤0.01% | 2936 |
|
2015
Q4 | $69K | Sell |
12,409
-6,567
| -35% | -$36.5K | ﹤0.01% | 3039 |
|
2015
Q3 | $161K | Sell |
18,976
-23
| -0.1% | -$195 | ﹤0.01% | 2803 |
|
2015
Q2 | $287K | Buy |
18,999
+2,674
| +16% | +$40.4K | ﹤0.01% | 2539 |
|
2015
Q1 | $261K | Buy |
16,325
+2,375
| +17% | +$38K | ﹤0.01% | 2496 |
|
2014
Q4 | $249K | Sell |
13,950
-414
| -3% | -$7.39K | ﹤0.01% | 2456 |
|
2014
Q3 | $144K | Buy |
14,364
+4,105
| +40% | +$41.2K | ﹤0.01% | 2770 |
|
2014
Q2 | $160K | Buy |
10,259
+6,049
| +144% | +$94.3K | ﹤0.01% | 2745 |
|
2014
Q1 | $78K | Sell |
4,210
-17,384
| -81% | -$322K | ﹤0.01% | 3109 |
|
2013
Q4 | $412K | Buy |
21,594
+18,650
| +633% | +$356K | ﹤0.01% | 2150 |
|
2013
Q3 | $48K | Buy |
+2,944
| New | +$48K | ﹤0.01% | 3188 |
|